ArticleInvestigational new drugs2014

Reduced folate carrier (RFC) as a predictive marker for response to pemetrexed in advanced non-small cell lung cancer (NSCLC).

Carlos Alvarez-Fernandez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.